Gothenburg, Sweden

Ingrid Bolin

This inventor holds 1 USPTO granted patent. Top assignee: Astra Aktiebolag. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingrid Bolin. Retrieved from https://idiyas.com/inventor/ingrid-bolin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ingrid Bolin

Introduction

Ingrid Bolin is a notable inventor based in Goteborg, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of bacterial antigens and vaccine compositions. Her work is essential in advancing medical science and improving public health.

Latest Patents

Ingrid Bolin holds a patent for bacterial antigens and vaccine compositions. This patent represents her innovative approach to addressing health challenges through scientific research and development. The patent showcases her expertise and commitment to enhancing vaccine efficacy.

Career Highlights

Ingrid Bolin is currently employed at Astra Aktiebolag, a leading pharmaceutical company. Her role at Astra allows her to collaborate with other experts in the field and contribute to groundbreaking research. Her career is marked by a dedication to innovation and a passion for improving healthcare solutions.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Ingrid Bolin's contributions to the field of biotechnology through her patent and work at Astra Aktiebolag highlight her as a significant figure in medical innovation. Her efforts continue to pave the way for advancements in vaccine development and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…